| Cathy Schmid, RN | |
|
1395 Eisenhower Dr, Savannah, GA 31406-3901 | |
| (912) 256-2868 | |
| Not Available |
| Full Name | Cathy Schmid |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1395 Eisenhower Dr, Savannah, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073916409 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN075691 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cathy Schmid, RN 150 Scranton Connector, Brunswick, GA 31525-0540 Ph: () - | Cathy Schmid, RN 1395 Eisenhower Dr, Savannah, GA 31406-3901 Ph: (912) 256-2868 |
News Archive
More than 5 million individuals in the United States suffer from chronic heart failure, making it one of the most common reasons for hospitalizations and readmissions. To address this costly issue, the New Jersey Hospital Association's Institute for Quality and Patient Safety this week launched a yearlong collaborative partnership to reduce hospital readmissions due to heart failure and improve the quality of healthcare in New Jersey.
In a discovery suggesting that odors may have a far more important role in life than previously believed, scientists have found that heart, blood, lung and other cells in the body have the same receptors for sensing odors that exist in the nose.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, presented new pre-clinical data from its ALN-TTR program at the XII International Symposium on Amyloidosis in Rome on April 18 - 21, 2010. ALN-TTR01 is a systemically delivered RNAi therapeutic being developed for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR), including familial amyloidotic polyneuropathy (FAP) and familial amyloidotic cardiomyopathy (FAC).
A bevy of legislation is flooding Capitol Hill on healthcare reform. With President Obama's speech kicking debate on these initiatives into high gear, Eric Zimmerman, a partner in the Health Law Department of leading law firm McDermott Will & Emery, weighs in on the issues:
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
› Verified 9 days ago
Yasmeen Nixon, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 24 Oglethorpe Professional Blvd, Savannah, GA 31406 Phone: 912-644-5812 | |
Deanna Lynn Quincy, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1395 Eisenhower Dr, Savannah, GA 31406 Phone: 912-356-2158 | |
Angela M Wilkinson, CRNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 Mohawk Street, Suite A, Savannah, GA 31419 Phone: 912-920-2090 Fax: 912-920-4114 | |
Joshua R Kohl, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 5353 Reynolds St, Savannah, GA 31405 Phone: 912-355-7214 Fax: 912-354-2479 | |
Carli A Boatright, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4750 Waters Ave Suite 206, Savannah, GA 31404 Phone: 912-350-5915 | |
Amanda Lewis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 459 Mall Blvd Apt 99, Savannah, GA 31406 Phone: 912-220-4435 | |
Eleanor Quincy, FNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 315 Eisenhower Dr, Savannah, GA 31406 Phone: 912-354-4687 Fax: 912-495-8881 |